Aderse eents did not differ significantly between the risedronate and placebo groups, the inestigators say. 研究人员说,治疗组和安慰剂组的不良反应发生率无显著差异。
Although myalgia and pyrexia were more common in treatment groups, dropout rates related to treatment were similar to those in the placebo group. 尽管治疗组中,肌痛与发热更为常见,但由于治疗反应而推出的比例,与安慰剂组类似。